{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:16:11Z","timestamp":1761714971034,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.pcd.2012.09.002","type":"journal-article","created":{"date-parts":[[2012,11,20]],"date-time":"2012-11-20T02:02:04Z","timestamp":1353376924000},"page":"63-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predictors of postprandial blood glucose response to biphasic insulin analogue therapy"],"prefix":"10.1016","volume":"7","author":[{"given":"Vito","family":"Borz\u00ec","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Benroubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz","family":"Gumprecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuzo","family":"Kawamori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Ligthelm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Shaban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddharth","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Shestakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Wenying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Valensi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcd.2012.09.002_bib0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/157016109787354169","article-title":"Postprandial glucose \u2013 a potential therapeutic target to reduce cardiovascular mortality","volume":"7","author":"Peter","year":"2009","journal-title":"Current Vascular Pharmacology"},{"key":"10.1016\/j.pcd.2012.09.002_bib0010","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1463-1326.2007.00743.x","article-title":"Adding biphasic insulin aspart 30 once or twice daily is more efficacious than optimizing oral antidiabetic treatment in patients with type 2 diabetes","volume":"9","author":"Bebakar","year":"2007","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1016\/j.pcd.2012.09.002_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1463-1326.2007.00796.x","article-title":"Addition of biphasic insulin aspart 30 to optimised metformin and pioglitazone treatment of type 2 diabetes mellitus: the ACTION Study (Achieving Control Through Insulin plus Oral ageNts)","volume":"11","author":"Raskin","year":"2009","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1016\/j.pcd.2012.09.002_bib0020","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2337\/diacare.28.2.260","article-title":"Initiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogs","volume":"28","author":"Raskin","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2012.09.002_bib0025","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1185\/03007990903354674","article-title":"Once-daily initiation with biphasic insulin aspart 30 versus insulin glargine in patients with type 2 diabetes inadequately controlled with oral drugs: an open-label, multinational RCT","volume":"25","author":"Strojek","year":"2009","journal-title":"Current Medical Research and Opinion"},{"key":"10.1016\/j.pcd.2012.09.002_bib0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF03345673","article-title":"Biphasic insulin aspart 30: better glycemic control than with premixed human insulin 30 in obese patients with type 2 diabetes","volume":"32","author":"Velojic-Golubovic","year":"2009","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.pcd.2012.09.002_bib0035","doi-asserted-by":"crossref","first-page":"852","DOI":"10.2337\/dc07-1992","article-title":"Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen, without increasing hypoglycemia, in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs","volume":"31","author":"Yang","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2012.09.002_bib0040","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.clinthera.2007.07.004","article-title":"Importance of observational studies in clinical practice","volume":"29","author":"Ligthelm","year":"2007","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/j.pcd.2012.09.002_bib0045","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1742-1241.2009.02012.x","article-title":"Safety and effectiveness of biphasic insulin aspart 30\/70 (NovoMix 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE\u2122 observational study","volume":"63","author":"Shah","year":"2009","journal-title":"International Journal of Clinical Practice"},{"key":"10.1016\/j.pcd.2012.09.002_bib0050","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1742-1241.2009.02002.x","article-title":"Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30\/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE\u2122 observational study","volume":"63","author":"Valensi","year":"2009","journal-title":"International Journal of Clinical Practice"},{"key":"10.1016\/j.pcd.2012.09.002_bib0055","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/j.1742-1241.2008.01917.x","article-title":"The IMPROVE\u2122 study \u2013 a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts","volume":"62","author":"Valensi","year":"2008","journal-title":"International Journal of Clinical Practice"},{"key":"10.1016\/j.pcd.2012.09.002_bib0060","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2337\/diacare.26.3.881","article-title":"Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycaemia of type 2 diabetic patients: variations with increasing levels of HbA(1c)","volume":"26","author":"Monnier","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2012.09.002_bib0065","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2337\/dc06-1612","article-title":"The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes","volume":"30","author":"Monnier","year":"2007","journal-title":"Diabetes Care"},{"issue":"Suppl. 1","key":"10.1016\/j.pcd.2012.09.002_bib0070","first-page":"S348","article-title":"Improved glycaemic control in over 11,000 elderly patients from the IMPROVE\u2122 Study of biphasic insulin aspart 30\/70 (BIAsp 30) in eight countries","volume":"52","author":"Borz\u00ec","year":"2009","journal-title":"Diabetologia"}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991812001088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991812001088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:54:36Z","timestamp":1761695676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751991812001088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1751991812001088"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2012.09.002","relation":{},"ISSN":["1751-9918"],"issn-type":[{"type":"print","value":"1751-9918"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of postprandial blood glucose response to biphasic insulin analogue therapy","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2012.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}